NGM Biopharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel biologic drug candidates. Its programs include NGM707 and pembrolizumab for treating metastatic solid tumors, Aldafermin for primary sclerosing cholangitis, and NGM120 for hyperemesis gravidarum. The company was founded by Jin Long Chen on December 20, 2007 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
138
Frequently Asked Questions
What is Market Cap of Ngm Biopharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Ngm Biopharmaceuticals Inc market cap is $128.53M.
What is the 52-week high for Ngm Biopharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Ngm Biopharmaceuticals Inc 52 week high is $4.69 as of September 29, 2025.
What is the 52-week low for Ngm Biopharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Ngm Biopharmaceuticals Inc 52 week low is $0.6002 as of September 29, 2025.
What is Ngm Biopharmaceuticals Inc stock price today?
Ngm Biopharmaceuticals Inc stock price today is $1.54.
What was Ngm Biopharmaceuticals Inc stock price yesterday?
Ngm Biopharmaceuticals Inc stock price yesterday was $1.56.
What is the PE ratio of Ngm Biopharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Ngm Biopharmaceuticals Inc’s P/E ratio is -0.89.
What is the Price-to-Book ratio of Ngm Biopharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Ngm Biopharmaceuticals Inc P/B ratio is 0.8590.
What is Ngm Biopharmaceuticals Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Ngm Biopharmaceuticals Inc's EBITDA is 0.53.
What is the 50-day moving average of Ngm Biopharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Ngm Biopharmaceuticals Inc 50-day moving average is $1.55.
How many employess does Ngm Biopharmaceuticals Inc has?
